Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Exploring Eye Vergence Markers ADHD) and ASD

View source ↗

Summary

A clinical trial is investigating eye vergence markers as potential biomarkers or informative measures for ADHD and autism spectrum disorder, with the study cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elizabeth Kilbey | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD) | Status: ACTIVE_NOT_RECRUITING